Form EFFECT InMed Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 30, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ECLAT Health Solutions to Showcase evaire Surface for ACO Total Cost of Care Management at NAACOS Fall 2026 Conference
- Arirang TV Showcases the Future of Korea's Sports Innovation to the World
- Ethereum Price Prediction: Why ETH Whales Enter AlphaPepe Presale for a 50x Launch Gains
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share